NCT06614842

Brief Summary

The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of psychotherapy as opposed to specific forms of psychotherapy that may require specific trainings or education.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 26, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

January 17, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

June 18, 2026

Status Verified

June 1, 2026

Enrollment Period

12 months

First QC Date

September 24, 2024

Last Update Submit

June 17, 2026

Conditions

Keywords

common factors psychotherapy

Outcome Measures

Primary Outcomes (6)

  • Generalized Anxiety Disorder-7 Screener

    Measure of anxiety symptoms. High scores more symptoms.

    At enrollment and at the end of treatment at 6 weeks

  • Patient Health Questionnaire-9 Screener

    Measure of depressive symptoms. High scores more symptoms.

    At enrollment and at the end of treatment at 6 weeks

  • Patient Checklist-5

    Measure of post-traumatic stress symptoms. High scores more symptoms.

    At enrollment and at the end of treatment at 6 weeks

  • Yale-Brown Obsessive Compulsive Scale

    Measure of obsessive compulsive disorder symptoms. High scores more symptoms.

    At enrollment and at the end of treatment at 6 weeks

  • Alcohol Use Disorders Identification Test

    Measure of concerning alcohol use. High scores more symptoms.

    At enrollment and at the end of treatment at 6 weeks

  • National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test

    Measure of substance use. High scores more use.

    At enrollment and at the end of treatment at 6 weeks

Secondary Outcomes (2)

  • Life Quality Scale

    At enrollment and at the end of treatment at 6 weeks

  • Experiential Avoidance Rating Scale

    At enrollment and at the end of treatment at 6 weeks

Other Outcomes (1)

  • Therapeutic Alliance Scale

    At conclusion of therapy after 6 weeks.

Study Arms (1)

Common Factors Group Therapy

EXPERIMENTAL

We will use a general common factors psychotherapy utilizing only psychotherapeutic techniques common to most forms of psychotherapy (e.g., listening and communication skills)

Behavioral: Common Factors Group Psychotherapy

Interventions

This intervention will not contain active ingredients from established specific forms of psychotherapy (e.g., cognitive-behavioral therapy, dialectical behavioral therapy)

Common Factors Group Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years old
  • Experiencing self-reported psychological distress

You may not qualify if:

  • has engaged in self-harm within the last three months
  • has attempted suicide within the last year
  • has had an active plan to attempt suicide within the last 30 days
  • currently diagnosed with any eating disorder
  • has experienced hallucinations or delusions within the last 30 days
  • has used narcotics within the last 7 days (heroin, meth, crack cocaine, opioids)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depressive Disorder, MajorGeneralized Anxiety DisorderStress Disorders, Post-TraumaticMental Disorders

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersAnxiety DisordersStress Disorders, TraumaticTrauma and Stressor Related Disorders

Study Officials

  • Nicholas Borgogna, PhD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
  • Drew Whittington, MS, MA

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 24, 2024

First Posted

September 26, 2024

Study Start

January 17, 2025

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

June 18, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

All de-identified data collected will be available2

Time Frame
When results are published
Access Criteria
Requesting researchers

Locations